Mineralys Cash from 2010 to 2025
| MLYS Stock | 10.24 0.04 0.39% |
Cash | First Reported 2010-12-31 | Previous Quarter 114.1 M | Current Value 57.9 M | Quarterly Volatility 36.2 M |
Check Mineralys Therapeutics, financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Mineralys Therapeutics,'s main balance sheet or income statement drivers, such as Net Interest Income of 15.3 M, Depreciation And Amortization of 143.6 K or Interest Expense of 2 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 3.28. Mineralys financial statements analysis is a perfect complement when working with Mineralys Therapeutics, Valuation or Volatility modules.
Mineralys | Cash |
Latest Mineralys Therapeutics,'s Cash Growth Pattern
Below is the plot of the Cash of Mineralys Therapeutics, Common over the last few years. Cash refers to the most liquid asset of Mineralys Therapeutics,, which is listed under current asset account on Mineralys Therapeutics, Common balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from Mineralys Therapeutics, customers. The amounts must be unrestricted with restricted cash listed in a different Mineralys Therapeutics, account. It is the total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts. Mineralys Therapeutics,'s Cash historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Mineralys Therapeutics,'s overall financial position and show how it may be relating to other accounts over time.
| Cash | 10 Years Trend |
|
Cash |
| Timeline |
Mineralys Cash Regression Statistics
| Arithmetic Mean | 20,943,296 | |
| Geometric Mean | 4,290,130 | |
| Coefficient Of Variation | 172.63 | |
| Mean Deviation | 28,151,069 | |
| Median | 1,409,000 | |
| Standard Deviation | 36,153,719 | |
| Sample Variance | 1307.1T | |
| Range | 112.7M | |
| R-Value | 0.71 | |
| Mean Square Error | 689.2T | |
| R-Squared | 0.51 | |
| Significance | 0 | |
| Slope | 5,411,634 | |
| Total Sum of Squares | 19606.4T |
Mineralys Cash History
Other Fundumenentals of Mineralys Therapeutics,
Mineralys Therapeutics, Cash component correlations
Click cells to compare fundamentals
About Mineralys Therapeutics, Financial Statements
Mineralys Therapeutics, shareholders use historical fundamental indicators, such as Cash, to determine how well the company is positioned to perform in the future. Although Mineralys Therapeutics, investors may analyze each financial statement separately, they are all interrelated. The changes in Mineralys Therapeutics,'s assets and liabilities, for example, are also reflected in the revenues and expenses on on Mineralys Therapeutics,'s income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Cash | 114.1 M | 57.9 M | |
| Cash And Short Term Investments | 198.2 M | 122.5 M | |
| Change In Cash | 64.8 M | 68 M | |
| Free Cash Flow | -166.4 M | -158.1 M | |
| Begin Period Cash Flow | 49.3 M | 32.8 M | |
| Total Cashflows From Investing Activities | -19.6 M | -20.6 M | |
| Other Cashflows From Financing Activities | 83 K | 78.8 K | |
| Other Non Cash Items | 117 K | 122.8 K | |
| Total Cash From Operating Activities | -166.3 M | -158 M | |
| Total Cash From Financing Activities | 116.1 M | 104.5 M | |
| End Period Cash Flow | 114.1 M | 57.9 M | |
| Other Cashflows From Investing Activities | -19.6 K | -20.6 K | |
| Free Cash Flow Yield | (0.28) | (0.26) | |
| Operating Cash Flow Per Share | (3.43) | (3.26) | |
| Free Cash Flow Per Share | (3.43) | (3.26) | |
| Cash Per Share | 4.08 | 2.18 | |
| EV To Operating Cash Flow | (2.91) | (3.05) | |
| EV To Free Cash Flow | (2.91) | (3.05) | |
| Price To Operating Cash Flows Ratio | (3.59) | (3.77) | |
| Price To Free Cash Flows Ratio | (3.59) | (3.77) | |
| Cash Ratio | 7.79 | 4.12 | |
| Free Cash Flow Operating Cash Flow Ratio | 0.90 | 0.80 | |
| Cash Flow Coverage Ratios | (0.49) | (0.52) | |
| Price Cash Flow Ratio | (3.59) | (3.77) | |
| Cash Flow To Debt Ratio | (0.49) | (0.52) |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Mineralys Stock Analysis
When running Mineralys Therapeutics,'s price analysis, check to measure Mineralys Therapeutics,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mineralys Therapeutics, is operating at the current time. Most of Mineralys Therapeutics,'s value examination focuses on studying past and present price action to predict the probability of Mineralys Therapeutics,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mineralys Therapeutics,'s price. Additionally, you may evaluate how the addition of Mineralys Therapeutics, to your portfolios can decrease your overall portfolio volatility.